Dr. Marc Ceulemans SRL

Dr. Marc Ceulemans reported total assets of 611,034 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).

Company number (CBE) 0888.366.679 · VAT BE0888366679
2840 Rumst
active in General medical practice activities (NACE 86210)
operating since 29 Mar 2007 (≈ 19 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Dr. Marc Ceulemans shows with a free account.

See the score
Profile
SRL since 2007
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result86,098 €
Equity606,283 €
Cash73,089 €
EBITDA143,579 €
Total assets611,034 €
Solvency99.2%
The line marks its sector median: 72.4% (5478 companies).

Change 2022 → 2025: Equity +59 % Total assets +59 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Dr. Marc Ceulemans's annual accounts

20252024202320222021
Net result86,098 €
Equity606,283 €
Cash73,089 €
EBITDA143,579 €
Total assets611,034 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 22 Jun 2026
  • Year ended 31 Dec 2024filed on 03 Jul 2025
  • Year ended 31 Dec 2023filed on 14 Jul 2024
  • Year ended 31 Dec 2022filed on 19 Jul 2023
  • Year ended 31 Dec 2021filed on 04 Jul 2022

Dr. Marc Ceulemans's financial analysis

Management and control of Dr. Marc Ceulemans

1 active director(s) in the register.

Dr. Marc Ceulemans's shareholders and holdings →

Dr. Marc Ceulemans's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0888.366.679
VAT number
BE0888366679
Peppol
Registered · 0208:0888366679 · as of 10 Nov 2026
Legal form
SRL
Incorporated
29 Mar 2007
Registered office
2840 Rumst
Latest accounts
2025 · filed on 22 Jun 2026
Activity
General medical practice activities (NACE 86210)

Dr. Marc Ceulemans (SRL) has been based in Rumst since 2007, active in: general medical practice activities. For 2025, it reports a net profit of 86,098 € and equity of 606,283 €; its revenue is not published. Its solvency stands at 99.2%, above the median of its sector (72.4%).

Companies similar to Dr. Marc Ceulemans

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Dr. Marc Ceulemans

What is the revenue of Dr. Marc Ceulemans?

Dr. Marc Ceulemans files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Dr. Marc Ceulemans?

In Belgium, the VAT number is the company number prefixed with BE: BE0888366679 for Dr. Marc Ceulemans, if the company is VAT-registered. Its company number (CBE) is 0888.366.679.

Where is the registered office of Dr. Marc Ceulemans?

According to the CBE register, the registered office of Dr. Marc Ceulemans is in 2840 Rumst.

What is the equity of Dr. Marc Ceulemans?

At the close of the 2025 financial year, the equity of Dr. Marc Ceulemans amounts to 606,283 €, a solvency of 99.2% of total assets.

Who manages Dr. Marc Ceulemans?

The register lists 1 active mandates at Dr. Marc Ceulemans. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Dr. Marc Ceulemans

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Aug 2026

No credit card, no commitment.

What each plan unlocks →